Boston Scientific Corp. (BSX)
44.39
+0.25
(+0.57%)
USD |
NYSE |
Oct 16, 16:00
44.28
-0.11
(-0.25%)
After-Hours: 20:00
Boston Scientific Cash from Investing (Quarterly) : -1.956B for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.956B |
| March 31, 2026 | -591.00M |
| December 31, 2025 | -512.00M |
| September 30, 2025 | -502.00M |
| June 30, 2025 | -1.126B |
| March 31, 2025 | -500.00M |
| December 31, 2024 | -3.704B |
| September 30, 2024 | -1.427B |
| June 30, 2024 | -271.00M |
| March 31, 2024 | -285.00M |
| December 31, 2023 | -1.053B |
| September 30, 2023 | -197.00M |
| June 30, 2023 | -840.00M |
| March 31, 2023 | -484.00M |
| December 31, 2022 | -183.00M |
| September 30, 2022 | -225.00M |
| June 30, 2022 | -29.00M |
| March 31, 2022 | -1.574B |
| December 31, 2021 | -461.00M |
| September 30, 2021 | -1.207B |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 71.00M |
| December 31, 2020 | -147.00M |
| September 30, 2020 | -129.00M |
| June 30, 2020 | -59.00M |
| Date | Value |
|---|---|
| March 31, 2020 | -76.00M |
| December 31, 2019 | -49.00M |
| September 30, 2019 | -3.962B |
| June 30, 2019 | -620.00M |
| March 31, 2019 | -410.00M |
| December 31, 2018 | -595.00M |
| September 30, 2018 | -662.00M |
| June 30, 2018 | -491.00M |
| March 31, 2018 | -173.00M |
| December 31, 2017 | -289.00M |
| September 30, 2017 | -102.00M |
| June 30, 2017 | -479.00M |
| March 31, 2017 | -140.00M |
| December 31, 2016 | -532.00M |
| September 30, 2016 | -205.00M |
| June 30, 2016 | -102.00M |
| March 31, 2016 | -48.00M |
| December 31, 2015 | -170.00M |
| September 30, 2015 | -1.719B |
| June 30, 2015 | -246.00M |
| March 31, 2015 | -51.00M |
| December 31, 2014 | -83.00M |
| September 30, 2014 | -473.00M |
| June 30, 2014 | -124.00M |
| March 31, 2014 | -65.00M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Abbott Laboratories | -673.00M |
| Becton, Dickinson & Co. | -228.00M |
| Stryker Corp. | -639.00M |
| The Cooper Cos., Inc. | -69.80M |
| Intuitive Surgical, Inc. | -26.60M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 1.474B |
| Cash from Financing (Quarterly) | -410.00M |
| Free Cash Flow | 3.625B |
| Free Cash Flow Per Share (Quarterly) | 0.8672 |
| Free Cash Flow to Equity (Quarterly) | -316.00M |
| Free Cash Flow to Firm (Quarterly) | 1.368B |
| Free Cash Flow Yield | 5.48% |